TrkA is a binding partner of NPM-ALK that promotes the survival of ALK+T-cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TrkA is a binding partner of NPM-ALK that promotes the survival of ALK+T-cell lymphoma

Published:2017-06-18 Issue:9 Volume:11 Page:1189-1207
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Shi Wenyu¹²,George Suraj Konnath¹,George Bhawana¹,Curry Choladda V.³,Murzabdillaeva Albina¹,Alkan Serhan⁴,Amin Hesham M.¹⁵

Affiliation:

1. Department of Hematopathology; The University of Texas MD Anderson Cancer Center; Houston TX USA

2. Department of Hematology; Affiliated Hospital of the University of Nantong; Jiangsu China

3. Department of Pathology and Immunology; Baylor College of Medicine & Texas Children's Hospital; Houston TX USA

4. Department of Pathology and Laboratory Medicine; Cedars-Sinai Medical Center; Los Angeles CA USA

5. MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences; Houston TX USA

Funder

National Cancer Institute

National Natural Science Foundation of China

Six Top Talent Foundation of Jiangsu Province

International Cooperation and Exchanges

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/1878-0261.12088/fullpdf

Reference71 articles.

1. Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia;Al-Jamal;BMC Cancer,2015

2. Pathobiology of ALK+ anaplastic large-cell lymphoma;Amin;Blood,2007

3. Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma;Amin;Oncogene,2004

4. Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma;Amin;Oncogene,2003

5. The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma;Atsaves;Br J Haematol,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleophosmin1 (NPM1) abnormality in hematologic malignancies, and therapeutic targeting of mutant NPM1 in acute myeloid leukemia;Therapeutic Advances in Hematology;2020-01

2. Up-regulated GGA3 promotes non-small cell lung cancer proliferation by regulating TrkA receptor;Translational Cancer Research;2019-11

3. Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma;Journal of Hematology & Oncology;2019-07-24

4. The γ-secretase inhibitor GSI-I interacts synergistically with the proteasome inhibitor bortezomib to induce ALK+ anaplastic large cell lymphoma cell apoptosis;Cellular Signalling;2019-07

5. The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII;Journal of Experimental & Clinical Cancer Research;2018-06-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3